deng yue

nuovo articolo creato

2 d - Tradurre

Luvometinib: Exploring New Frontiers in Targeted Therapy—From MET-Altered Lung Cancer to a Broad Multi-Tumor Strategy | #cancer #met

Luvometinib: Exploring New Frontiers in Targeted Therapy—From MET-Altered Lung Cancer to a Broad Multi-Tumor Strategy

Luvometinib: Exploring New Frontiers in Targeted Therapy—From MET-Altered Lung Cancer to a Broad Multi-Tumor Strategy

Lumosertib is an oral small molecule drug that belongs to the MET kinase inhibitor class. It is mainly used to treat patients with tumors carrying specific gene mutations, such as advanced or metastatic cancers in non-small cell lung cancer (NSCLC) driven by MET exon14 skipping mutations.

Mi piace

Commento

Condividi

Cambiato sua immagine del profilo

2 d

Mi piace

Commento

Condividi

Carica piu notizie

Informazioni

2 messaggi
Femmina
12/20/03
Residente a China

Albums

0

0

0

0

Gruppi

0